Male bladder cancer vulnerability could lead to a new treatment approach
A protein variant common in malignant bladder tumor cells may serve as a new avenue for treating bladder cancer. A multi-institution study led by UC Davis Comprehensive Cancer Center researchers found that targeting androgen receptors – a type of protein that is crucial for the function of testosterone – may destroy cancer cells. The study,…